Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Managed Care Interface|December 29, 2007
The Medicare Part D doughnut hole: effect on pharmacy utilizationShawn X Sun, Kwan Y Lee
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
Health Affairs (Project Hope)|November 6, 2007
The impact of Medicare Part D on prescription drug use by the elderlyFrank R Lichtenberg, Shawn X Sun
American Health & Drug Benefits|September 9, 2016
Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD ExacerbationQing Lee, Michelle Mocarski, Shawn X Sun
The Joint Commission Journal on Quality Improvement|March 21, 2002
Using comparison charts to assess performance measurement dataKwan Y Lee, Christine McGreevey
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 1, 2022
Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional StudyPing Du, George Morgan, Sarah Brighton, et al.
Managed Care (Langhorne, Pa.)|September 25, 2015
Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and CostsRahul Jain, Qian Cai, Shawn X Sun, et al.
Pageof 5